Business Update

Company updates financial status, anticipates anthrax vaccine delivery in 2006

Published in Vaccine Weekly, December 7th, 2005

VaxGen, Inc. (VXGN.PK) announced that it expects to file all of its currently outstanding financial statements on a rolling basis in the first quarter of 2006.

Additionally, the company expects to file an annual report on Form 10-K for the year ended December 31, 2005 and to be current with all of its financial statements in the second quarter of 2006. VaxGen expects to apply for relisting on the Nasdaq as soon as it is current with all of its financial statements.

Since its last update in July 2005, VaxGen has made significant progress toward filing its financial statements. An independent valuation of Celltrion, Inc., VaxGen's minority owned...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2005-12-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry